Berge; Rolf

Patent Applications and Registrations

Patent applications and USPTO patent grants for Berge; Rolf.The latest application filed is for "composition comprising plant and/or fish oils and non-oxidizable fatty acid entities".

Company Profile

0.9.13

Berge; Rolf - Bones NO
Berge; Rolf - B{acute over o
Berge; Rolf - Norway NO
Berge; Rolf - B.o slashed.nes NO
Berge; Rolf - B.phi.nes NO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition Comprising Plant And/or Fish Oils And Non-oxidizable Fatty Acid Entities App 20120276212 - Berge; Rolf	2012-11-01
Fish protein hydrolyzate Grant 8,206,739 - Berge June 26, 2	2012-06-26
Fatty Acid Analogues For The Treatment Of Inflammatory And Autoimmune Disorders App 20120101161 - Berge; Rolf ; et al.	2012-04-26
Fatty acid analogues for the treatment of inflammatory and autoimmune disorders Grant 8,088,825 - Berge , et al. January 3, 2	2012-01-03
Fatty acids analogous Grant 7,902,399 - Berge , et al. March 8, 2	2011-03-08
Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities Grant 7,659,242 - Berge February 9, 2	2010-02-09
Fatty acid analogues for equilibrating bone mineral density App 20100029973 - Berge; Rolf	2010-02-04
Fatty acid analogues for the treatment of cancer Grant 7,378,443 - Berge May 27, 2	2008-05-27
Use of a single-cell protein material App 20070141083 - Berge; Rolf ; et al.	2007-06-21
Fish protein hydrolyzate App 20070142274 - Berge; Rolf	2007-06-21
Fatty acid analogues for the treatment of proliferative skin disorders Grant 7,230,029 - Berge , et al. June 12, 2	2007-06-12
Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities App 20070015795 - Berge; Rolf	2007-01-18
Composition comprising plant and/or fish oils and compounds comprising non-oxidizable fatty acid entities App 20070009608 - Berge; Rolf	2007-01-11
Sulfur-containing phospholipid derivatives App 20060105987 - Miller; Andrew David ; et al.	2006-05-18
Fatty acid analogues for the treatment of diseases caused by the pathological proliferation of smooth muscle cells Grant 7,026,356 - Berge April 11, 2	2006-04-11
Fatty acid analogues for the treatment of inflammatory and autoimmune disorders App 20050165103 - Berge, Rolf ; et al.	2005-07-28
Novel fatty acids analogous App 20040213442 - Berge, Rolf ; et al.	2004-10-28
Fatty acid analogues for the treatment of cancer App 20040024063 - Berge, Rolf	2004-02-05
Fatty acid analogues for the treatment of proliferative skin disorders App 20040019108 - Berge, Rolf ; et al.	2004-01-29
Novel fatty acid analogues for the treatment and prevention of diseases caused by the pathological proliferation of smooth muscle cells App 20020198259 - Berge, Rolf	2002-12-26
Fatty analogues for the treatment of obesity, hypertension and fatty liver Grant 6,441,036 - Berge August 27, 2	2002-08-27
Fatty analogues for the treatment of diabetes Grant 6,365,628 - Berge April 2, 2	2002-04-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.